Real-world practice patterns and impact of PD-L1 expression testing in patients with advanced non-small cell lung cancer.

被引:0
|
作者
Leapman, Michael
Presley, Carolyn J.
Zhu, Weiwei
Soulos, Pamela R.
Adelson, Kerin B.
Boffa, Daniel J.
Gross, Cary Philip
机构
[1] Yale Sch Med, New Haven, CT USA
[2] Ohio State Univ, Columbus, OH 43210 USA
[3] Yale Univ, New Haven, CT USA
[4] Yale Sch Med, Thorac Surg Sect, Dept Surg, New Haven, CT USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
9059
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Real-World PD-L1 Testing Patterns for Patients with Advanced Non-Small Cell Lung Cancer in Greece
    Kokkotou, E.
    Charpidou, A.
    Papaspiliou, A.
    Stournara, L.
    Grammatikou, V.
    Ejzykowicz, F.
    Syrigos, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S660 - S660
  • [2] PD-L1 Testing Patterns and Treatment in Patients With Metastatic Non-Small Cell Lung Cancer in Israel - Analysis of Real-World Data
    Apter, L.
    Moser, S. Sharman
    Arunachalam, A.
    Burke, T.
    Shalev, V.
    Chodick, G.
    Siegelmann-Danieli, N.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S307 - S308
  • [3] Prevalence of PD-L1 Expression in Non-Small Cell Lung Cancer: a Real-World Australian Perspective
    Prabhakaran, S.
    Russell, P. A.
    Farrall, A. L.
    Asadi, K.
    Barrett, W.
    Cooper, C.
    Cooper, W.
    Duhig, E. E.
    Egan, M.
    Fox, S.
    Godbolt, D.
    Gupta, S.
    Cotton, S.
    Leslie, C.
    Leong, T.
    Moffat, D.
    Qiu, M.
    Sivasubramaniam, V.
    Snell, C.
    Skerman, J.
    Walsh, M.
    Whale, K.
    Klebe, S.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S479 - S479
  • [4] Characterizing the Shifting Real-World Treatment Landscape by PD-L1 Testing Status and Expression Level in Advanced Non-Small Cell Lung Cancer
    Ge, Wenzhen
    Wu, Ning
    Quek, Ruben G. W.
    Liu, Jinjie
    Pouliot, Jean-Francois
    Dietz, Hilary
    Jalbert, Jessica J.
    Harnett, James
    Antonia, Scott J.
    ADVANCES IN THERAPY, 2022, 39 (10) : 4645 - 4662
  • [5] Characterizing the Shifting Real-World Treatment Landscape by PD-L1 Testing Status and Expression Level in Advanced Non-Small Cell Lung Cancer
    Wenzhen Ge
    Ning Wu
    Ruben G. W. Quek
    Jinjie Liu
    Jean-Francois Pouliot
    Hilary Dietz
    Jessica J. Jalbert
    James Harnett
    Scott J. Antonia
    Advances in Therapy, 2022, 39 : 4645 - 4662
  • [6] PD-L1 expression testing in non-small cell lung cancer
    Teixido, Cristina
    Vilarino, Noelia
    Reyes, Roxana
    Reguart, Noemi
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10
  • [7] Molecular correlates of PD-L1 expression in patients with non-small cell lung cancer.
    Rizvi, Hira
    Bandlamudi, Chaitanya
    Schoenfeld, Adam Jacob
    Sauter, Jennifer L.
    Arbour, Kathryn Cecilia
    Beras, Amanda
    Egger, Jacklynn V.
    Ladanyi, Marc
    Donoghue, Mark
    Rudin, Charles M.
    Taylor, Barry S.
    Hellmann, Matthew David
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Real-World Outcomes for Advanced Non-Small Cell Lung Cancer Patients Treated With a PD-L1 Inhibitor Beyond Progression
    Stinchcombe, Thomas E.
    Miksad, Rebecca A.
    Gossai, Anala
    Griffith, Sandra D.
    Torres, Aracelis Z.
    CLINICAL LUNG CANCER, 2020, 21 (05) : 389 - +
  • [9] A real-world study of PD-L1 testing patterns and PD-1/PD-L1 inhibitor therapy in patients with metastatic non-small cell lung cancer: An analysis of the Sotiria Hospital lung cancer registry
    Charpidou, Andriani
    Syrigos, Nikolaos K.
    Kokkotou, Eleni
    Stournara, Lamprini
    Mani, Maria
    Tsagouli, Sofia
    Burke, Thomas
    Spanoudi, Filio
    Desiniotis, Andreas
    Dimitriadis, Ioannis
    Gkiozos, Ioannis
    PNEUMON, 2024,
  • [10] Real-world practice patterns of providers managing older patients with non-small cell lung cancer.
    Das, Devika Govind
    Bhatia, Avnish K.
    Wujcik, Debra
    Owenby, Susie
    Hall, Wanda D.
    Smith, Tasha
    Zinner, Ralph
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (27)